SPT — AGM Information 2020

Jul 17, 2020

ScinoPharm Taiwan, Ltd. Notice of 2020 Annual General Shareholders’ Meeting (Summary Translation)

1. Shareholders are encouraged to exercise their voting rights through TDCC’s e-Voting service during the COVID-19 (Novel Coronavirus Disease 2019) pandemic. If shareholders intend to attend Shareholders’ Meeting, each shareholder shall put on a face mask at all times. Our staffs will help measuring body temperature at the entrance. If the temperature is higher than 37.5 ° C (forehead temperature) or 38 ° C (ear temperature), shareholders won’t be allowed to enter the meeting site.

2. In case that the meeting site is changed due to pandemic, please refer to the MOPS material information.

The 2020 Annual General Shareholders’ Meeting (the “Meeting”) of ScinoPharm Taiwan, Ltd. (the “Company”) will be convened at 10:00 a.m., Tuesday, June 30, 2020 at Wellness Center STSP (No. 20, Sec. 2, Huandong Rd., Shanhua Dist., Tainan City 741, Taiwan).

1. The agenda for the Meeting is as follows:

   • I. Report Items

     • (1) 2019 Business Report.

     • (2) Audit Committee’s Review Report on 2019 Financial Results.

     • (3) 2019 Compensations for Employees and Directors.

     • (4) Proposed Amendments to the Rules of Procedure for Board of Directors Meeting of the Company.

   • II. Ratification Items

     • (1) Ratification of 2019 Business Report and Financial Statements.

     • (2) Ratification of the Proposed Distribution of 2019 Earnings.

   • III. Discussion Items

     • (1) Proposed Amendments to the Articles of Incorporation of the Company.

     • (2) Proposed Amendments to the Rules of Governing Election of Directors and Supervisors of the Company.

     • (3) Proposed Amendments to the Rules of Procedures for Shareholders’ Meeting of the Company.

     • (4) Proposed release of Director’s Non-Compete Restrictions.

   • IV. Extemporary motions

2. Proposal for distribution of 2019 profits has been resolved by the Board of Directors as follows:

Cash dividends: Totaling NT$213,499,590 the proposed dividends is NT$0.27 per share. Upon the approval of Annual Meeting of Shareholders, it is proposed that the Board of Directors be authorized to resolve the ex-dividend date.

1

1. Pursuant to Article 165 of the Company Act, the Company hereby closes the share transfer registration from May 2, 2020 to June 30, 2020.

2. If any shareholder solicits for a proxy, the Company will disclose the summarization of the solicitation prepared by the Company on the website of the Securities and Futures Institute (http://free.sfi.org.tw) on May 29, 2020. If any investor wishes to make inquiries, please log into the “free inquiry system for published information of proxy” on the website, and click the right side “entrance to published information of proxy” and input the key words for the inquiry.

3. The shareholder’s voting power of this annual shareholders' meeting may be exercised by way of electronic transmission, and the exercising period will be from May 30, 2020 through June 27, 2020. Please log in the “Stockvote” established by Taiwan Depository & Clearing Corporation at http://www.stockvote.com.tw.

4. The institution for tallying and verifying proxy forms of 2020 general shareholders’ meeting is Stock Registration Department, President Securities Corporation.

5. If there exist any matters that shall be itemized in the causes and the essential contents thereof shall be explained pursuant to Article 172 of the Company Law, the essential contents can be found at the Market Observation Post System (http://mops.twse.com.tw). Please log into said website, and click “electronic books”, key in the Year “2020,” select the code of the Company “1789,” and read references related to the shareholders’ meeting.

Board of Directors ScinoPharm Taiwan, Ltd.

2